MEK-IN-1

• Description:

  MEK-IN-1 is a MEK inhibitor extracted from patent WO2008076415A1.

• UNSPSC:

  12352005

• Target:

  MEK

• Type:

  Reference compound

• Related Pathways:

  MAPK/ERK Pathway

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/Carbamic_acid,_N-[6-[2,3-dihydro-1-hydroxy-3-oxo-2-_phenylmethyl_-1H-isoindol-1-yl]-1H-benzimidazol-2-yl]-,_methyl_ester.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(OC)NC1=NC2=CC=C(C3(O)N(CC4=CC=CC=C4)C(C5=C3C=CC=C5)=O)C=C2N1

• Molecular Formula:

  C24H20N4O4

• Molecular Weight:

  428.44

• References & Citations:

  [1]Lamb P, et al. Methods of using mek inhibitors. WO2008076415A1.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• Isoform:

  MEK

• CAS Number:

  [870600-45-6]